Is This Peanut Allergy Treatment Back on the Table?
DBV Technologies is making a comeback after making headway for its peanut allergy treatment in Europe.
Chris Lange
3 months ago

20 Biopharma Stocks for Huge Upside Potential in 2020
Here are 20 biotechnology and pharmaceutical stocks that have been given big analyst upside targets for 2020.
Jon C. Ogg
1 year ago
Last Updated: 1 year ago

Why This Peanut Allergy Study Was Worth the Wait
DBV Tech shares jumped on Thursday after the firm announced positive topline results from its late-stage study in children with a peanut allergy.
Chris Lange
1 year ago
Last Updated: 1 year ago

Top Analyst Upgrades and Downgrades: AMD, Amex, Apache, Coca-Cola, Ford, GM, Goldman Sachs, Lyft, Snap, Starbucks, Tesla and More
Thursday's top analyst upgrades, downgrades and initiations included AMD, Amex, Apache, Coca-Cola, Ford, GM, Goldman Sachs, Lyft, Snap, Starbucks and Tesla.
Jon C. Ogg
1 year ago
Last Updated: 1 year ago

Major Step Forward in Peanut Allergy Treatment
DBV Technologies shares dipped on Monday after the firm announced an update from the FDA. Although it was a positive update for the company, this appears to be a case of “sell the news.”
Chris Lange
1 year ago
Last Updated: 1 year ago

Revolutionary Peanut Allergy Treatment Is One Step Closer
DBV Tech shares shot up on Thursday after the company announced the submission of paperwork to the FDA for Viaskin Peanut for the treatment of peanut-allergic children.
Chris Lange
1 year ago
Last Updated: 1 year ago

Top Analyst Upgrades and Downgrades: DBV Tech, Keurig Dr. Pepper, Deere, Dow, GNC, Kinder Morgan, Mosaic, Symantec, Walt Disney and More
Stocks were indicated to open marginally higher on Monday after gains of about 0.4% for the Dow and S&P 500 last week. This summer Monday is not seeing any vast amounts of new news rattling the...
Jon C. Ogg
1 year ago
Last Updated: 1 year ago

Why DBV Technologies Is Changing Up Senior Leadership
DBV Technologies shares made a handy gain on Thursday after the company announced that it would be making some changes in its senior leadership ahead of its anticipated resubmission of its Viaskin...
Chris Lange
2 years ago
Last Updated: 1 year ago

Meet Thursday's Biggest Biotech Movers
Thursday was a breakout day for a few biotech companies. Some made absolutely massive runs, while others fell off a cliff.
Chris Lange
2 years ago
Last Updated: 1 year ago

30 Big Biotech Events Coming in 2018
Jefferies has compiled a list of over 30 biotech events taking place in 2018 that could result in significant stock moves. Some stocks have the potential to double or even crater, should a study be...
Chris Lange
3 years ago
Last Updated: 1 year ago

Eldorado Gold, DBV Technologies Crash into Monday's 52-Week Low Club
Weatherford Intertational, Eldorado Gold, DBV Technologies, and Kinder Morgan all posted new 52-week lows Monday.
Paul Ausick
3 years ago
Last Updated: 1 year ago

The Tale of 2 Biotechs: Aimmune vs DBV Tech
The tale of two biotechs appears to be playing out between Aimmune Therapeutics and DBV Technologies, not just for the companies but between analysts as well.
Chris Lange
3 years ago
Last Updated: 1 year ago

Top Analyst Upgrades and Downgrades: Biogen, Equifax, Foot Locker, GE, NVIDIA, Rio Tinto, Roku and More
The top analyst upgrades, downgrades and other research calls from Monday include Biogen, Equifax, Foot Locker, General Electric, NVIDIA, Rio Tinto and Roku.
Jon C. Ogg
3 years ago
Last Updated: 11 months ago

DBV Technologies Files for IPO, Sort Of
DBV Technologies has filed an F-1 form with the U.S. Securities and Exchange Commission (SEC) for an initial public offering
Chris Lange
6 years ago
Last Updated: 6 years ago